4
Changes in Ownership
Veradermics, Inc Filed Acc 0001628280-26-057816
Chief Technical Officer sold 43,500 shares at an average $107.82 ($4,690,005)
- Chief Technical Officer acquired 3,452 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Durso Timothy August · Chief Technical Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,452 | $12.19 | $42,080 | 121,642 | D |
| 2026-08-17 | Sale : show line 2 in the form 10b5-1 | −7,918 | $106.71 | $844,930 | 113,724 | D |
| 2026-08-17 | Sale : show line 3 in the form 10b5-1 | −16,306 | $107.52 | $1,753,221 | 97,418 | D |
| 2026-08-17 | Sale : show line 4 in the form 10b5-1 | −16,767 | $108.38 | $1,817,207 | 80,651 | D |
| 2026-08-17 | Sale : show line 5 in the form 10b5-1 | −2,348 | $109.34 | $256,730 | 78,303 | D |
| 2026-08-17 | Sale : show line 6 in the form 10b5-1 | −161 | $111.28 | $17,916 | 78,142 | D |
| Open-market sales · 43,500 sh · avg $107.82 · $4,690,005 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-17 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −3,452 | 0 | D |
Loading xslF345X06/wk-form4_1787101799.xml…